Esplora la scienza dietro il rapamicina e il suo potenziale per la longevità attraverso conversazioni coinvolgenti con esperti del settore. Scopri intuizioni che contano.
Joan Mannick on Rapamycin Longevity Series | Turning down mTOR to young levels may be good for aging
S1 E8 • 82 mins • Jan 17, 2024
Charts
- 130Increased by 4
- 28Decreased by 7
- 145NEW
- 193NEW
- 159NEW
Episodi recenti
![](https://files.podcastos.com/shows/pwzhmh/jpeg256-58a86ac7.jpg)
Jan 17, 2024
Joan Mannick on Rapamycin Longevity Series | Turning down mTOR to young levels may be good for aging
S1 E8 • 82 mins
![](https://files.podcastos.com/shows/pwzhmh/jpeg256-58a86ac7.jpg)
Oct 17, 2023
Brian Kennedy on Rapamycin Master Series | Aging is the biggest risk factor for age-related diseases
S1 E7 • 71 mins
![](https://files.podcastos.com/shows/pwzhmh/jpeg256-58a86ac7.jpg)
Aug 22, 2023
Mikhail Blagosklonny on Rapamycin Longevity Series | mTOR drives age-related diseases
S1 E6 • 102 mins
![](https://files.podcastos.com/shows/pwzhmh/jpeg256-58a86ac7.jpg)
Jul 11, 2023
Brad Stanfield on Rapamycin Longevity Series | Rapamycin, mTOR and the importance of muscle in life
S1 E5 • 76 mins
![](https://files.podcastos.com/shows/pwzhmh/jpeg256-58a86ac7.jpg)
Jun 14, 2023
Pankaj Kapahi on Rapamycin Longevity Series | There is no one size longevity intervention that fits all
S1 E4 • 68 mins
![](https://files.podcastos.com/shows/pwzhmh/jpeg-baff0220.jpg)
Lingua
Inglese
Paese
Svezia
Sito web
Feed
Richiedi un aggiornamento
Gli aggiornamenti potrebbero richiedere alcuni minuti.